Stim2Go

Next Gen
Neurostimulation

"Welcome, I want to help you. Customer Service "Thank you very much for your inquiry. We will get in touch with you as soon as possible."
Please select your country and I will find your next customer service."

Spasticity Reduction

Stim2Go can be used to mitigate lower limb spasticity after spinal cord injury and in patients with multiple sclerosis through the application of non-invasive transcutaneous spinal cord stimulation (tSCS). The stimulation is typically performed in a supine or standing posture, and its effects may last for several hours. The application of tSCS can also be incorporated into secured gait therapy to further enhance gait rehabilitation in cases of incomplete spinal cord injury.

The spasticity reduction programs are available only within the scope of MDR approval and are not cleared for market by the FDA.

List of programs
 

Spasticity reduction 50 Hz 1CH 

Summary (as HTML) 


Description (as PDF)

Spasticity reduction 33 Hz 1CH

Summary (as HTML) 


Description (as PDF)

Not all products are registered and approved for sale in all countries or regions. Indications of use may also vary by country and region. Please contact your country representative for product availability and information. Product images are for reference only.